Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / COM
-
Number of holders
-
2163
-
Total 13F shares, excl. options
-
1.3B
-
Shares change
-
+7.32M
-
Total reported value, excl. options
-
$113B
-
Value change
-
+$655M
-
Put/Call ratio
-
0.96
-
Number of buys
-
828
-
Number of sells
-
-899
-
Price
-
$86.86
Significant Holders of ABBOTT LABORATORIES - COM (ABT) as of Q4 2019
2,302 filings reported holding ABT - ABBOTT LABORATORIES - COM as of Q4 2019.
ABBOTT LABORATORIES - COM (ABT) has 2,163 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.3B shares
.
Largest 10 shareholders include VANGUARD GROUP INC (152M shares), BlackRock Inc. (125M shares), Capital Research Global Investors (114M shares), STATE STREET CORP (73.6M shares), Capital International Investors (47.3M shares), WELLINGTON MANAGEMENT GROUP LLP (38.6M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (31M shares), NORTHERN TRUST CORP (26.7M shares), BANK OF AMERICA CORP /DE/ (25.1M shares), and GEODE CAPITAL MANAGEMENT, LLC (25M shares).
This table shows the top 2163 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.